SOKOLOFF; Pierre

Patent Applications and Registrations

Patent applications and USPTO patent grants for SOKOLOFF; Pierre.The latest application filed is for "flt3 inhibitors for improving pain treatments by opioids".

Company Profile

1.7.11

SOKOLOFF; Pierre - Ile aux Moines FR
Sokoloff; Pierre - Belleserre FR
Sokoloff; Pierre - Le Plessis Bouchard FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Flt3 Inhibitors For Improving Pain Treatments By Opioids App 20200171022 - VALMIER; Jean ; et al.	2020-06-04
Chromone derivative as a dopamine D3 receptor antagonist for its use for the treatment of autism spectrum disorder Grant 10,028,948 - Auclair , et al. July 24, 2	2018-07-24
Chromone Derivative As A Dopamine D3 Receptor Antagonist For Its Use For The Treatment Of Autism Spectrum Disorder App 20160303117 - AUCLAIR; Agnes ; et al.	2016-10-20
Derivatives of azaindazole or diazaindazole type for treating pain Grant 9,381,195 - Sokoloff , et al. July 5, 2	2016-07-05
Novel Benzodioxane-piperidine Derivatives And Their Therapeutic Applications For Treating Neuropsychiatric Disorders App 20150336943 - SOKOLOFF; Pierre ; et al.	2015-11-26
Derivatives Of Azaindazole Or Diazaindazole Type For Treating Pain App 20150190394 - Sokoloff; Pierre ; et al.	2015-07-09
Levomilnacipran-based Drug For Functional Recovery After Acute Neurological Events App 20140179794 - Sokoloff; Pierre	2014-06-26
Chromone derivatives, a process for their preparation and their therapeutic applications Grant 8,546,402 - Sokoloff , et al. October 1, 2	2013-10-01
Chromone Derivatives, A Process For Their Preparation And Their Therapeutic Applications App 20120157463 - Sokoloff; Pierre ; et al.	2012-06-21
3,4-dihydro-2-naphthamide derivatives as selective dopamine D3 ligands Grant 7,875,617 - Sokoloff , et al. January 25, 2	2011-01-25
Novel Chromene And Thiochromene Carboxamide Derivatives, Methods For Preparing Same And Therapeutic Applications Of Same App 20100029682 - Sokoloff; Pierre ; et al.	2010-02-04
Use Of 1,7-dimethylxanthine For The Manufacture Of A Non-anxiogenic Psychoanaleptic Drug For The Treatment Of A Neuropsychiatric Disorder App 20090325984 - Costentin; Jean ; et al.	2009-12-31
Essential Tremor Diagnostic And Treatment App 20090209551 - Sokoloff; Pierre ; et al.	2009-08-20
3, 4-dihydro-2-naphthamide Derivatives As Selective Dopamine D3 Ligands App 20090124630 - Sokoloff; Pierre ; et al.	2009-05-14
2-naphthamide derivatives and their therapeutic applications Grant 5,985,895 - Wermuth , et al. November 16, 1	1999-11-16
2-Naphthamide derivatives and their therapeutic applications Grant 5,872,119 - Wermuth , et al. February 16, 1	1999-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.